124 related articles for article (PubMed ID: 34275027)
1. RMI2 is a prognostic biomarker and promotes tumor growth in hepatocellular carcinoma.
Li Y; He X; Zhang X; Xu Y; Chen W; Liu X; Xu X
Clin Exp Med; 2022 May; 22(2):229-243. PubMed ID: 34275027
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
[TBL] [Abstract][Full Text] [Related]
3. The Clinical Significance of RMI2 in Hepatocellular Carcinoma.
Zheng Ms B; Wang Ms H; Wang Ms JX; Liu Ms ZH; Zhang Md P; Zhang Md D
Technol Cancer Res Treat; 2021; 20():15330338211045496. PubMed ID: 34634948
[No Abstract] [Full Text] [Related]
4. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis.
Zhang M; Wang W; Li T; Yu X; Zhu Y; Ding F; Li D; Yang T
Biomed Pharmacother; 2016 May; 80():73-79. PubMed ID: 27133041
[TBL] [Abstract][Full Text] [Related]
6. RecQ mediated genome instability 2 (
Wei W; Ying X; Chen L; Sun Q; Lu X; Xia Y; Xu R; Zhu Z; Zhang D; Tang Q; Li L; Xie J; Yu H
Aging (Albany NY); 2022 May; 14(9):4107-4136. PubMed ID: 35552266
[TBL] [Abstract][Full Text] [Related]
7. Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis.
Chen DB; Zhao YJ; Wang XY; Liao WJ; Chen P; Deng KJ; Cong X; Fei R; Wu X; Shao QX; Wei L; Xie XW; Chen HS
Chin Med J (Engl); 2019 Jul; 132(13):1572-1581. PubMed ID: 31188160
[TBL] [Abstract][Full Text] [Related]
8. RMI2 is a novel prognostic and predictive biomarker for breast cancer.
Zhang L; Hao C; Han B; Zeng G; Han L; Cao C; Liu H; Zhong Z; Zhao X; Wang J; Zhang Q
Cancer Med; 2023 Apr; 12(7):8331-8350. PubMed ID: 36533385
[TBL] [Abstract][Full Text] [Related]
9. Cell division cycle associated 2 (CDCA2) upregulation promotes the progression of hepatocellular carcinoma in a p53-dependant manner.
Wang J; Liu X; Chu H; Chen J
PeerJ; 2022; 10():e13535. PubMed ID: 35694386
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-645 represses hepatocellular carcinoma progression by inhibiting SOX30-mediated p53 transcriptional activation.
Tao J; Liu Z; Wang Y; Wang L; Yin G; Yang W; Tu K; Liu Q
Int J Biol Macromol; 2019 Jan; 121():214-222. PubMed ID: 30312695
[TBL] [Abstract][Full Text] [Related]
11. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B.
Ying H; Ji L; Xu Z; Fan X; Tong Y; Liu H; Zhao J; Cai X
Cancer Lett; 2020 Mar; 473():13-24. PubMed ID: 31875525
[TBL] [Abstract][Full Text] [Related]
12. ZNF498 promotes hepatocellular carcinogenesis by suppressing p53-mediated apoptosis and ferroptosis via the attenuation of p53 Ser46 phosphorylation.
Zhang X; Zheng Q; Yue X; Yuan Z; Ling J; Yuan Y; Liang Y; Sun A; Liu Y; Li H; Xu K; He F; Wang J; Wu J; Zhao C; Tian C
J Exp Clin Cancer Res; 2022 Feb; 41(1):79. PubMed ID: 35227287
[TBL] [Abstract][Full Text] [Related]
13. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
[TBL] [Abstract][Full Text] [Related]
14. Non-coding small nucleolar RNA SNORD17 promotes the progression of hepatocellular carcinoma through a positive feedback loop upon p53 inactivation.
Liang J; Li G; Liao J; Huang Z; Wen J; Wang Y; Chen Z; Cai G; Xu W; Ding Z; Liang H; Datta PK; Chu L; Chen X; Zhang B
Cell Death Differ; 2022 May; 29(5):988-1003. PubMed ID: 35034103
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
16. Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways.
Chen SL; Liu LL; Wang CH; Lu SX; Yang X; He YF; Zhang CZ; Yun JP
Mol Oncol; 2020 Feb; 14(2):373-386. PubMed ID: 31670863
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
18. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of MARCO associates with tumor progression in hepatocellular carcinoma.
Xiao Y; Chen B; Yang K; Wang Q; Liu P; Gu Y; Zhong Q; Liu Z; He Y; Liu Q
Exp Cell Res; 2019 Oct; 383(2):111542. PubMed ID: 31381879
[TBL] [Abstract][Full Text] [Related]
20. Flap endonuclease 1 Facilitated Hepatocellular Carcinoma Progression by Enhancing USP7/MDM2-mediated P53 Inactivation.
Bian S; Ni W; Zhu M; Zhang X; Qiang Y; Zhang J; Ni Z; Shen Y; Qiu S; Song Q; Xiao M; Zheng W
Int J Biol Sci; 2022; 18(3):1022-1038. PubMed ID: 35173534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
